Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1995 Sep;2(5):518–523. doi: 10.1128/cdli.2.5.518-523.1995

X-linked severe combined immunodeficiency disease and the gamma c receptor component: prospects for molecular diagnosis.

N L Farner 1, S D Voss 1, P M Sondel 1
PMCID: PMC170193  PMID: 8548528

Full Text

The Full Text of this article is available as a PDF (200.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carson W. E., Giri J. G., Lindemann M. J., Linett M. L., Ahdieh M., Paxton R., Anderson D., Eisenmann J., Grabstein K., Caligiuri M. A. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med. 1994 Oct 1;180(4):1395–1403. doi: 10.1084/jem.180.4.1395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Conley M. E., Buckley R. H., Hong R., Guerra-Hanson C., Roifman C. M., Brochstein J. A., Pahwa S., Puck J. M. X-linked severe combined immunodeficiency. Diagnosis in males with sporadic severe combined immunodeficiency and clarification of clinical findings. J Clin Invest. 1990 May;85(5):1548–1554. doi: 10.1172/JCI114603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Conley M. E., Lavoie A., Briggs C., Brown P., Guerra C., Puck J. M. Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency. Proc Natl Acad Sci U S A. 1988 May;85(9):3090–3094. doi: 10.1073/pnas.85.9.3090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Conley M. E. Molecular approaches to analysis of X-linked immunodeficiencies. Annu Rev Immunol. 1992;10:215–238. doi: 10.1146/annurev.iy.10.040192.001243. [DOI] [PubMed] [Google Scholar]
  5. DiSanto J. P., Keever C. A., Small T. N., Nicols G. L., O'Reilly R. J., Flomenberg N. Absence of interleukin 2 production in a severe combined immunodeficiency disease syndrome with T cells. J Exp Med. 1990 May 1;171(5):1697–1704. doi: 10.1084/jem.171.5.1697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Giri J. G., Ahdieh M., Eisenman J., Shanebeck K., Grabstein K., Kumaki S., Namen A., Park L. S., Cosman D., Anderson D. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 1994 Jun 15;13(12):2822–2830. doi: 10.1002/j.1460-2075.1994.tb06576.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Grabstein K. H., Eisenman J., Shanebeck K., Rauch C., Srinivasan S., Fung V., Beers C., Richardson J., Schoenborn M. A., Ahdieh M. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science. 1994 May 13;264(5161):965–968. doi: 10.1126/science.8178155. [DOI] [PubMed] [Google Scholar]
  8. Hatakeyama M., Tsudo M., Minamoto S., Kono T., Doi T., Miyata T., Miyasaka M., Taniguchi T. Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's. Science. 1989 May 5;244(4904):551–556. doi: 10.1126/science.2785715. [DOI] [PubMed] [Google Scholar]
  9. Hong R. Update on the immunodeficiency diseases. Am J Dis Child. 1990 Sep;144(9):983–992. doi: 10.1001/archpedi.1990.02150330043019. [DOI] [PubMed] [Google Scholar]
  10. Ihle J. N. The Janus kinase family and signaling through members of the cytokine receptor superfamily. Proc Soc Exp Biol Med. 1994 Jul;206(3):268–272. doi: 10.3181/00379727-206-43757. [DOI] [PubMed] [Google Scholar]
  11. Iseki M., Heiner D. C. Immunodeficiency disorders. Pediatr Rev. 1993 Jun;14(6):226–236. doi: 10.1542/pir.14-6-226. [DOI] [PubMed] [Google Scholar]
  12. Ishii N., Asao H., Kimura Y., Takeshita T., Nakamura M., Tsuchiya S., Konno T., Maeda M., Uchiyama T., Sugamura K. Impairment of ligand binding and growth signaling of mutant IL-2 receptor gamma-chains in patients with X-linked severe combined immunodeficiency. J Immunol. 1994 Aug 1;153(3):1310–1317. [PubMed] [Google Scholar]
  13. Ishii N., Takeshita T., Kimura Y., Tada K., Kondo M., Nakamura M., Sugamura K. Expression of the IL-2 receptor gamma chain on various populations in human peripheral blood. Int Immunol. 1994 Aug;6(8):1273–1277. doi: 10.1093/intimm/6.8.1273. [DOI] [PubMed] [Google Scholar]
  14. Johnston J. A., Kawamura M., Kirken R. A., Chen Y. Q., Blake T. B., Shibuya K., Ortaldo J. R., McVicar D. W., O'Shea J. J. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature. 1994 Jul 14;370(6485):151–153. doi: 10.1038/370151a0. [DOI] [PubMed] [Google Scholar]
  15. Kinnon C., Levinsky R. The molecular basis of X-linked immunodeficiency disease. J Inherit Metab Dis. 1992;15(4):674–682. doi: 10.1007/BF01799623. [DOI] [PubMed] [Google Scholar]
  16. Kirken R. A., Rui H., Malabarba M. G., Farrar W. L. Identification of interleukin-2 receptor-associated tyrosine kinase p116 as novel leukocyte-specific Janus kinase. J Biol Chem. 1994 Jul 22;269(29):19136–19141. [PubMed] [Google Scholar]
  17. Kondo M., Takeshita T., Higuchi M., Nakamura M., Sudo T., Nishikawa S., Sugamura K. Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. Science. 1994 Mar 11;263(5152):1453–1454. doi: 10.1126/science.8128231. [DOI] [PubMed] [Google Scholar]
  18. Kondo M., Takeshita T., Ishii N., Nakamura M., Watanabe S., Arai K., Sugamura K. Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science. 1993 Dec 17;262(5141):1874–1877. doi: 10.1126/science.8266076. [DOI] [PubMed] [Google Scholar]
  19. Lyon M. F. Mechanisms and evolutionary origins of variable X-chromosome activity in mammals. Proc R Soc Lond B Biol Sci. 1974 Nov 5;187(1088):243–268. doi: 10.1098/rspb.1974.0073. [DOI] [PubMed] [Google Scholar]
  20. Markiewicz S., DiSanto J. P., Chelly J., Fairweather N., Le Marec B., Griscelli C., Graeber M. B., Müller U., Fischer A., Monaco A. P. Fine mapping of the human SCIDX1 locus at Xq12-13.1. Hum Mol Genet. 1993 Jun;2(6):651–654. doi: 10.1093/hmg/2.6.651. [DOI] [PubMed] [Google Scholar]
  21. Minami Y., Kono T., Miyazaki T., Taniguchi T. The IL-2 receptor complex: its structure, function, and target genes. Annu Rev Immunol. 1993;11:245–268. doi: 10.1146/annurev.iy.11.040193.001333. [DOI] [PubMed] [Google Scholar]
  22. Minamoto S., Mori H., Hatakeyama M., Kono T., Doi T., Ide T., Uede T., Taniguchi T. Characterization of the heterodimeric complex of human IL-2 receptor alpha.beta chains reconstituted in a mouse fibroblast cell line, L929. J Immunol. 1990 Oct 1;145(7):2177–2182. [PubMed] [Google Scholar]
  23. Miyajima A., Kitamura T., Harada N., Yokota T., Arai K. Cytokine receptors and signal transduction. Annu Rev Immunol. 1992;10:295–331. doi: 10.1146/annurev.iy.10.040192.001455. [DOI] [PubMed] [Google Scholar]
  24. Miyazaki T., Kawahara A., Fujii H., Nakagawa Y., Minami Y., Liu Z. J., Oishi I., Silvennoinen O., Witthuhn B. A., Ihle J. N. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science. 1994 Nov 11;266(5187):1045–1047. doi: 10.1126/science.7973659. [DOI] [PubMed] [Google Scholar]
  25. Nakarai T., Robertson M. J., Streuli M., Wu Z., Ciardelli T. L., Smith K. A., Ritz J. Interleukin 2 receptor gamma chain expression on resting and activated lymphoid cells. J Exp Med. 1994 Jul 1;180(1):241–251. doi: 10.1084/jem.180.1.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Noguchi M., Nakamura Y., Russell S. M., Ziegler S. F., Tsang M., Cao X., Leonard W. J. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science. 1993 Dec 17;262(5141):1877–1880. doi: 10.1126/science.8266077. [DOI] [PubMed] [Google Scholar]
  27. Noguchi M., Yi H., Rosenblatt H. M., Filipovich A. H., Adelstein S., Modi W. S., McBride O. W., Leonard W. J. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell. 1993 Apr 9;73(1):147–157. doi: 10.1016/0092-8674(93)90167-o. [DOI] [PubMed] [Google Scholar]
  28. Pahwa R., Chatila T., Pahwa S., Paradise C., Day N. K., Geha R., Schwartz S. A., Slade H., Oyaizu N., Good R. A. Recombinant interleukin 2 therapy in severe combined immunodeficiency disease. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5069–5073. doi: 10.1073/pnas.86.13.5069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Puck J. M., Deschênes S. M., Porter J. C., Dutra A. S., Brown C. J., Willard H. F., Henthorn P. S. The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Hum Mol Genet. 1993 Aug;2(8):1099–1104. doi: 10.1093/hmg/2.8.1099. [DOI] [PubMed] [Google Scholar]
  30. Puck J. M., Krauss C. M., Puck S. M., Buckley R. H., Conley M. E. Prenatal test for X-linked severe combined immunodeficiency by analysis of maternal X-chromosome inactivation and linkage analysis. N Engl J Med. 1990 Apr 12;322(15):1063–1066. doi: 10.1056/NEJM199004123221508. [DOI] [PubMed] [Google Scholar]
  31. Puck J. M. Molecular and genetic basis of X-linked immunodeficiency disorders. J Clin Immunol. 1994 Mar;14(2):81–89. doi: 10.1007/BF01541340. [DOI] [PubMed] [Google Scholar]
  32. Puck J. M., Stewart C. C., Nussbaum R. L. Maximum-likelihood analysis of human T-cell X chromosome inactivation patterns: normal women versus carriers of X-linked severe combined immunodeficiency. Am J Hum Genet. 1992 Apr;50(4):742–748. [PMC free article] [PubMed] [Google Scholar]
  33. Puck J. M. X-linked immunodeficiencies. Adv Hum Genet. 1993;21:107–144. doi: 10.1007/978-1-4615-3010-7_2. [DOI] [PubMed] [Google Scholar]
  34. Ringheim G. E., Freimark B. D., Robb R. J. Quantitative characterization of the intrinsic ligand-binding affinity of the interleukin 2 receptor beta chain and its modulation by the alpha chain and a second affinity-modulating element. Lymphokine Cytokine Res. 1991 Jun;10(3):219–224. [PubMed] [Google Scholar]
  35. Robb R. J., Rusk C. M., Neeper M. P. Structure-function relationships for the interleukin 2 receptor: location of ligand and antibody binding sites on the Tac receptor chain by mutational analysis. Proc Natl Acad Sci U S A. 1988 Aug;85(15):5654–5658. doi: 10.1073/pnas.85.15.5654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Roest P. A., Roberts R. G., Sugino S., van Ommen G. J., den Dunnen J. T. Protein truncation test (PTT) for rapid detection of translation-terminating mutations. Hum Mol Genet. 1993 Oct;2(10):1719–1721. doi: 10.1093/hmg/2.10.1719. [DOI] [PubMed] [Google Scholar]
  37. Rosen F. S., Cooper M. D., Wedgwood R. J. The primary immunodeficiencies. (2). N Engl J Med. 1984 Aug 2;311(5):300–310. doi: 10.1056/NEJM198408023110506. [DOI] [PubMed] [Google Scholar]
  38. Russell S. M., Johnston J. A., Noguchi M., Kawamura M., Bacon C. M., Friedmann M., Berg M., McVicar D. W., Witthuhn B. A., Silvennoinen O. Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. Science. 1994 Nov 11;266(5187):1042–1045. doi: 10.1126/science.7973658. [DOI] [PubMed] [Google Scholar]
  39. Russell S. M., Keegan A. D., Harada N., Nakamura Y., Noguchi M., Leland P., Friedmann M. C., Miyajima A., Puri R. K., Paul W. E. Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science. 1993 Dec 17;262(5141):1880–1883. doi: 10.1126/science.8266078. [DOI] [PubMed] [Google Scholar]
  40. Schorle H., Holtschke T., Hünig T., Schimpl A., Horak I. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature. 1991 Aug 15;352(6336):621–624. doi: 10.1038/352621a0. [DOI] [PubMed] [Google Scholar]
  41. Smith K. A. Lowest dose interleukin-2 immunotherapy. Blood. 1993 Mar 15;81(6):1414–1423. [PubMed] [Google Scholar]
  42. Smith K. A. The interleukin 2 receptor. Annu Rev Cell Biol. 1989;5:397–425. doi: 10.1146/annurev.cb.05.110189.002145. [DOI] [PubMed] [Google Scholar]
  43. Sondel P. M., Voss S. D., Hong R. Addendum to SCID, interleukin-2, and the interleukin-2 receptor review. Blood. 1994 Jul 15;84(2):667–668. [PubMed] [Google Scholar]
  44. Stephan J. L., Vlekova V., Le Deist F., Blanche S., Donadieu J., De Saint-Basile G., Durandy A., Griscelli C., Fischer A. Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr. 1993 Oct;123(4):564–572. doi: 10.1016/s0022-3476(05)80951-5. [DOI] [PubMed] [Google Scholar]
  45. Takeshita T., Asao H., Ohtani K., Ishii N., Kumaki S., Tanaka N., Munakata H., Nakamura M., Sugamura K. Cloning of the gamma chain of the human IL-2 receptor. Science. 1992 Jul 17;257(5068):379–382. doi: 10.1126/science.1631559. [DOI] [PubMed] [Google Scholar]
  46. Takeshita T., Asao H., Suzuki J., Sugamura K. An associated molecule, p64, with high-affinity interleukin 2 receptor. Int Immunol. 1990;2(5):477–480. doi: 10.1093/intimm/2.5.477. [DOI] [PubMed] [Google Scholar]
  47. Takeshita T., Goto Y., Tada K., Nagata K., Asao H., Sugamura K. Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor. J Exp Med. 1989 Apr 1;169(4):1323–1332. doi: 10.1084/jem.169.4.1323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Takeshita T., Ohtani K., Asao H., Kumaki S., Nakamura M., Sugamura K. An associated molecule, p64, with IL-2 receptor beta chain. Its possible involvement in the formation of the functional intermediate-affinity IL-2 receptor complex. J Immunol. 1992 Apr 1;148(7):2154–2158. [PubMed] [Google Scholar]
  49. Tanaka N., Asao H., Ohbo K., Ishii N., Takeshita T., Nakamura M., Sasaki H., Sugamura K. Physical association of JAK1 and JAK2 tyrosine kinases with the interleukin 2 receptor beta and gamma chains. Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7271–7275. doi: 10.1073/pnas.91.15.7271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Taniguchi T., Minami Y. The IL-2/IL-2 receptor system: a current overview. Cell. 1993 Apr 9;73(1):5–8. doi: 10.1016/0092-8674(93)90152-g. [DOI] [PubMed] [Google Scholar]
  51. Tsudo M., Karasuyama H., Kitamura F., Tanaka T., Kubo S., Yamamura Y., Tamatani T., Hatakeyama M., Taniguchi T., Miyasaka M. The IL-2 receptor beta-chain (p70). Ligand binding ability of the cDNA-encoding membrane and secreted forms. J Immunol. 1990 Jul 15;145(2):599–606. [PubMed] [Google Scholar]
  52. Tsudo M., Kitamura F., Miyasaka M. Characterization of the interleukin 2 receptor beta chain using three distinct monoclonal antibodies. Proc Natl Acad Sci U S A. 1989 Mar;86(6):1982–1986. doi: 10.1073/pnas.86.6.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Voss S. D., Hong R., Sondel P. M. Severe combined immunodeficiency, interleukin-2 (IL-2), and the IL-2 receptor: experiments of nature continue to point the way. Blood. 1994 Feb 1;83(3):626–635. [PubMed] [Google Scholar]
  54. Voss S. D., Sondel P. M., Robb R. J. Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R gamma chain with the IL-2R beta chain in functional intermediate-affinity IL-2R. J Exp Med. 1992 Aug 1;176(2):531–541. doi: 10.1084/jem.176.2.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Waldmann T. A. The interleukin-2 receptor. J Biol Chem. 1991 Feb 15;266(5):2681–2684. [PubMed] [Google Scholar]
  56. Waldmann T. A. The multi-subunit interleukin-2 receptor. Annu Rev Biochem. 1989;58:875–911. doi: 10.1146/annurev.bi.58.070189.004303. [DOI] [PubMed] [Google Scholar]
  57. Weinberg K., Parkman R. Severe combined immunodeficiency due to a specific defect in the production of interleukin-2. N Engl J Med. 1990 Jun 14;322(24):1718–1723. doi: 10.1056/NEJM199006143222406. [DOI] [PubMed] [Google Scholar]
  58. Wengler G. S., Allen R. C., Parolini O., Smith H., Conley M. E. Nonrandom X chromosome inactivation in natural killer cells from obligate carriers of X-linked severe combined immunodeficiency. J Immunol. 1993 Jan 15;150(2):700–704. [PubMed] [Google Scholar]
  59. Wilks A. F., Harpur A. G. Cytokine signal transduction and the JAK family of protein tyrosine kinases. Bioessays. 1994 May;16(5):313–320. doi: 10.1002/bies.950160505. [DOI] [PubMed] [Google Scholar]
  60. de Saint Basile G., Arveiler B., Oberlé I., Malcolm S., Levinsky R. J., Lau Y. L., Hofker M., Debre M., Fischer A., Griscelli C. Close linkage of the locus for X chromosome-linked severe combined immunodeficiency to polymorphic DNA markers in Xq11-q13. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7576–7579. doi: 10.1073/pnas.84.21.7576. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES